海森药业高管减持计划实施中，涉及股份占总股本0.0816%

Core Viewpoint - Zhejiang Haisen Pharmaceutical Co., Ltd. plans to reduce its shareholding by a maximum of 124,300 shares, accounting for 0.0816% of the total share capital, due to personal funding needs [1] Group 1 - The share reduction will occur between December 26, 2025, and March 25, 2026, through centralized bidding transactions [1] - The reduction plan was announced on December 4, 2025, and is currently in the implementation phase [1]